Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation

Thomas Lehrnbecher, Robert Phillips, Sarah Alexander, Frank Alvaro, Fabianne Carlesse, Brian Fisher, Hana Hakim, Maria Santolaya, Elio Castagnola, Bonnie L. Davis, L. Lee Dupuis, Faith Gibson, Andreas H. Groll, Aditya Gaur, Ajay Gupta, Rejin Kebudi, Sérgio Petrilli, William J. Steinbach, Milena Villarroel, Theoklis ZaoutisLillian Sung

Research output: Contribution to journalArticle

201 Citations (Scopus)

Abstract

Purpose: To develop an evidence-based guideline for the empiric management of pediatric fever and neutropenia (FN). Methods: The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group composed of experts in pediatric oncology and infectious disease as well as a patient advocate. The Panel was convened for the purpose of creating this guideline. We followed previously validated procedures for creating evidence-based guidelines. Working groups focused on initial presentation, ongoing management, and empiric antifungal therapy. Each working group developed key clinical questions, conducted systematic reviews of the published literature, and compiled evidence summaries. The Grades of Recommendation Assessment, Development, and Evaluation approach was used to generate summaries, and evidence was classified as high, moderate, low, or very low based on methodologic considerations. Results: Recommendations were made related to initial presentation (risk stratification, initial evaluation, and treatment), ongoing management (modification and cessation of empiric antibiotics), and empiric antifungal treatment (risk stratification, evaluation, and treatment) of pediatric FN. For each recommendation, the strength of the recommendation and level of evidence are presented. Conclusion: This guideline represents an evidence-based approach to FN specific to children with cancer. Although some recommendations are similar to adult-based guidelines, there are key distinctions in multiple areas. Implementation will require adaptation to the local context.

Original languageEnglish
Pages (from-to)4427-4438
Number of pages12
JournalJournal of Clinical Oncology
Volume30
Issue number35
DOIs
Publication statusPublished - Dec 10 2012

Fingerprint

Hematopoietic Stem Cell Transplantation
Neutropenia
Fever
Guidelines
Pediatrics
Neoplasms
Antifungal Agents
Therapeutics
Communicable Diseases

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. / Lehrnbecher, Thomas; Phillips, Robert; Alexander, Sarah; Alvaro, Frank; Carlesse, Fabianne; Fisher, Brian; Hakim, Hana; Santolaya, Maria; Castagnola, Elio; Davis, Bonnie L.; Lee Dupuis, L.; Gibson, Faith; Groll, Andreas H.; Gaur, Aditya; Gupta, Ajay; Kebudi, Rejin; Petrilli, Sérgio; Steinbach, William J.; Villarroel, Milena; Zaoutis, Theoklis; Sung, Lillian.

In: Journal of Clinical Oncology, Vol. 30, No. 35, 10.12.2012, p. 4427-4438.

Research output: Contribution to journalArticle

Lehrnbecher, T, Phillips, R, Alexander, S, Alvaro, F, Carlesse, F, Fisher, B, Hakim, H, Santolaya, M, Castagnola, E, Davis, BL, Lee Dupuis, L, Gibson, F, Groll, AH, Gaur, A, Gupta, A, Kebudi, R, Petrilli, S, Steinbach, WJ, Villarroel, M, Zaoutis, T & Sung, L 2012, 'Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation', Journal of Clinical Oncology, vol. 30, no. 35, pp. 4427-4438. https://doi.org/10.1200/JCO.2012.42.7161
Lehrnbecher, Thomas ; Phillips, Robert ; Alexander, Sarah ; Alvaro, Frank ; Carlesse, Fabianne ; Fisher, Brian ; Hakim, Hana ; Santolaya, Maria ; Castagnola, Elio ; Davis, Bonnie L. ; Lee Dupuis, L. ; Gibson, Faith ; Groll, Andreas H. ; Gaur, Aditya ; Gupta, Ajay ; Kebudi, Rejin ; Petrilli, Sérgio ; Steinbach, William J. ; Villarroel, Milena ; Zaoutis, Theoklis ; Sung, Lillian. / Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. In: Journal of Clinical Oncology. 2012 ; Vol. 30, No. 35. pp. 4427-4438.
@article{926bc3ebd9804d82a2aaf45a25e57db3,
title = "Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation",
abstract = "Purpose: To develop an evidence-based guideline for the empiric management of pediatric fever and neutropenia (FN). Methods: The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group composed of experts in pediatric oncology and infectious disease as well as a patient advocate. The Panel was convened for the purpose of creating this guideline. We followed previously validated procedures for creating evidence-based guidelines. Working groups focused on initial presentation, ongoing management, and empiric antifungal therapy. Each working group developed key clinical questions, conducted systematic reviews of the published literature, and compiled evidence summaries. The Grades of Recommendation Assessment, Development, and Evaluation approach was used to generate summaries, and evidence was classified as high, moderate, low, or very low based on methodologic considerations. Results: Recommendations were made related to initial presentation (risk stratification, initial evaluation, and treatment), ongoing management (modification and cessation of empiric antibiotics), and empiric antifungal treatment (risk stratification, evaluation, and treatment) of pediatric FN. For each recommendation, the strength of the recommendation and level of evidence are presented. Conclusion: This guideline represents an evidence-based approach to FN specific to children with cancer. Although some recommendations are similar to adult-based guidelines, there are key distinctions in multiple areas. Implementation will require adaptation to the local context.",
author = "Thomas Lehrnbecher and Robert Phillips and Sarah Alexander and Frank Alvaro and Fabianne Carlesse and Brian Fisher and Hana Hakim and Maria Santolaya and Elio Castagnola and Davis, {Bonnie L.} and {Lee Dupuis}, L. and Faith Gibson and Groll, {Andreas H.} and Aditya Gaur and Ajay Gupta and Rejin Kebudi and S{\'e}rgio Petrilli and Steinbach, {William J.} and Milena Villarroel and Theoklis Zaoutis and Lillian Sung",
year = "2012",
month = "12",
day = "10",
doi = "10.1200/JCO.2012.42.7161",
language = "English",
volume = "30",
pages = "4427--4438",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "35",

}

TY - JOUR

T1 - Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation

AU - Lehrnbecher, Thomas

AU - Phillips, Robert

AU - Alexander, Sarah

AU - Alvaro, Frank

AU - Carlesse, Fabianne

AU - Fisher, Brian

AU - Hakim, Hana

AU - Santolaya, Maria

AU - Castagnola, Elio

AU - Davis, Bonnie L.

AU - Lee Dupuis, L.

AU - Gibson, Faith

AU - Groll, Andreas H.

AU - Gaur, Aditya

AU - Gupta, Ajay

AU - Kebudi, Rejin

AU - Petrilli, Sérgio

AU - Steinbach, William J.

AU - Villarroel, Milena

AU - Zaoutis, Theoklis

AU - Sung, Lillian

PY - 2012/12/10

Y1 - 2012/12/10

N2 - Purpose: To develop an evidence-based guideline for the empiric management of pediatric fever and neutropenia (FN). Methods: The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group composed of experts in pediatric oncology and infectious disease as well as a patient advocate. The Panel was convened for the purpose of creating this guideline. We followed previously validated procedures for creating evidence-based guidelines. Working groups focused on initial presentation, ongoing management, and empiric antifungal therapy. Each working group developed key clinical questions, conducted systematic reviews of the published literature, and compiled evidence summaries. The Grades of Recommendation Assessment, Development, and Evaluation approach was used to generate summaries, and evidence was classified as high, moderate, low, or very low based on methodologic considerations. Results: Recommendations were made related to initial presentation (risk stratification, initial evaluation, and treatment), ongoing management (modification and cessation of empiric antibiotics), and empiric antifungal treatment (risk stratification, evaluation, and treatment) of pediatric FN. For each recommendation, the strength of the recommendation and level of evidence are presented. Conclusion: This guideline represents an evidence-based approach to FN specific to children with cancer. Although some recommendations are similar to adult-based guidelines, there are key distinctions in multiple areas. Implementation will require adaptation to the local context.

AB - Purpose: To develop an evidence-based guideline for the empiric management of pediatric fever and neutropenia (FN). Methods: The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group composed of experts in pediatric oncology and infectious disease as well as a patient advocate. The Panel was convened for the purpose of creating this guideline. We followed previously validated procedures for creating evidence-based guidelines. Working groups focused on initial presentation, ongoing management, and empiric antifungal therapy. Each working group developed key clinical questions, conducted systematic reviews of the published literature, and compiled evidence summaries. The Grades of Recommendation Assessment, Development, and Evaluation approach was used to generate summaries, and evidence was classified as high, moderate, low, or very low based on methodologic considerations. Results: Recommendations were made related to initial presentation (risk stratification, initial evaluation, and treatment), ongoing management (modification and cessation of empiric antibiotics), and empiric antifungal treatment (risk stratification, evaluation, and treatment) of pediatric FN. For each recommendation, the strength of the recommendation and level of evidence are presented. Conclusion: This guideline represents an evidence-based approach to FN specific to children with cancer. Although some recommendations are similar to adult-based guidelines, there are key distinctions in multiple areas. Implementation will require adaptation to the local context.

UR - http://www.scopus.com/inward/record.url?scp=84870755899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870755899&partnerID=8YFLogxK

U2 - 10.1200/JCO.2012.42.7161

DO - 10.1200/JCO.2012.42.7161

M3 - Article

C2 - 22987086

AN - SCOPUS:84870755899

VL - 30

SP - 4427

EP - 4438

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 35

ER -